CA2535199C - Derives d'amide - Google Patents
Derives d'amide Download PDFInfo
- Publication number
- CA2535199C CA2535199C CA2535199A CA2535199A CA2535199C CA 2535199 C CA2535199 C CA 2535199C CA 2535199 A CA2535199 A CA 2535199A CA 2535199 A CA2535199 A CA 2535199A CA 2535199 C CA2535199 C CA 2535199C
- Authority
- CA
- Canada
- Prior art keywords
- group
- alkyl
- alkylene
- phenyl
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
L'invention concerne un composé utile dans des médicaments, notamment dans des médicaments destinés à diverses maladies engendrées par une infection aux virus appartenant à la famille Herpesviridae, notamment dans la prévention ou le traitement d'infections aux divers virus de l'herpès, et plus précisément, de la varicelle engendrée par l'infection au virus varicelle zona, de l'herpès zoster engendré par une infection récurrente au virus varicelle zoster persistant, de l'herpès labial et de l'encéphalite herpétique engendrés par une infection au HSV-1, de l'herpès génital engendré par une infection au HSV-2, etc. L'invention concerne enfin un dérivé de N-{2-[(4-phényle substitué)amino]-2-oxoéthyl}tétrahydro-2H-thiopyran-4-carboxamide comprenant un substituant hétéroaryle à 5 ou 6 chaînons spécifique au niveau de la position 4 et possédant une activité antivirale favorable permettant de traiter les maladies susmentionnées par administration orale d'une petite dose.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003290850 | 2003-08-08 | ||
JP2003-290850 | 2003-08-08 | ||
PCT/JP2004/011573 WO2005014559A1 (fr) | 2003-08-08 | 2004-08-05 | Derives d'amide |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2535199A1 CA2535199A1 (fr) | 2005-02-17 |
CA2535199C true CA2535199C (fr) | 2010-12-14 |
Family
ID=34114142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2535199A Active CA2535199C (fr) | 2003-08-08 | 2004-08-05 | Derives d'amide |
Country Status (19)
Country | Link |
---|---|
US (2) | US7465748B2 (fr) |
EP (1) | EP1652843B1 (fr) |
JP (1) | JP4549974B2 (fr) |
KR (1) | KR101157074B1 (fr) |
CN (1) | CN100445271C (fr) |
AU (1) | AU2004263448B2 (fr) |
BR (1) | BRPI0413430B8 (fr) |
CA (1) | CA2535199C (fr) |
CY (1) | CY1115461T1 (fr) |
DK (1) | DK1652843T3 (fr) |
ES (1) | ES2462292T3 (fr) |
MX (1) | MXPA06001526A (fr) |
NO (1) | NO335467B1 (fr) |
PL (1) | PL1652843T3 (fr) |
PT (1) | PT1652843E (fr) |
RU (1) | RU2336273C2 (fr) |
SI (1) | SI1652843T1 (fr) |
TW (1) | TW200505894A (fr) |
WO (1) | WO2005014559A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005518391A (ja) * | 2001-12-21 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | Gk活性化剤としてのアミド誘導体 |
JP4881559B2 (ja) * | 2002-06-27 | 2012-02-22 | ノボ・ノルデイスク・エー/エス | 治療薬としてのアリールカルボニル誘導体 |
TW200505894A (en) * | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
EP2444397A1 (fr) * | 2004-01-06 | 2012-04-25 | Novo Nordisk A/S | Hétéroaryl-urées et leur utilisation en tant qu'activateurs de glucokinase |
DE602006016069D1 (de) * | 2005-02-02 | 2010-09-23 | Astellas Pharma Inc | Therapeutischer wirkstoff zur behandlung von herpes progenitalis nach der entwicklung von läsionen |
EP1857108B1 (fr) * | 2005-02-02 | 2010-12-08 | Astellas Pharma Inc. | Agent preventif ou therapeutique contre une maladie liee au virus de l'herpes |
US20090048310A1 (en) * | 2005-02-02 | 2009-02-19 | Astellas Pharma Inc. | Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
JP5011739B2 (ja) * | 2005-02-03 | 2012-08-29 | アステラス製薬株式会社 | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物 |
AU2006268708A1 (en) * | 2005-07-08 | 2007-01-18 | Transtech Pharma Inc. | Dicycloalkyl urea glucokinase activators |
EP1904438B1 (fr) * | 2005-07-08 | 2012-02-29 | Novo Nordisk A/S | Dicycloalkylcarbamoylurées en tant qu' activateurs de glucokinase |
ES2422383T3 (es) | 2005-07-14 | 2013-09-11 | Novo Nordisk As | Activadores de urea glucoquinasa |
WO2008084043A1 (fr) * | 2007-01-09 | 2008-07-17 | Novo Nordisk A/S | Activateurs de la glucokinase à base d'urée |
JP5226008B2 (ja) * | 2007-01-11 | 2013-07-03 | ノボ・ノルデイスク・エー/エス | ウレアグルコキナーゼアクチベーター |
DE102008014523A1 (de) * | 2008-03-15 | 2009-09-17 | Robert Bosch Gmbh | Heizgerät |
EP2263671B1 (fr) * | 2008-04-02 | 2016-07-20 | Astellas Pharma Inc. | Composition pharmaceutique contenant un dérivé d'amide |
EP2565191B1 (fr) | 2008-05-14 | 2014-10-08 | Astellas Pharma Inc. | Dérivés d'acide 4-(indol-7-ylcarbonylaminométhyl)cyclohexanecarboxylique comme antagonistes du récepteur EP4 utilisables pour le traitement de l'insuffisance rénale chronique ou de la néphropathie diabétique |
EP2351565A1 (fr) | 2008-10-20 | 2011-08-03 | Astellas Pharma Inc. | Médicament destiné à la prévention ou au traitement de la douleur associée à un zona |
CN108623577B (zh) * | 2018-05-08 | 2020-09-25 | 山东百诺医药股份有限公司 | 阿莫奈韦及其中间体的制备方法 |
CN112040945A (zh) | 2018-06-12 | 2020-12-04 | Vtv治疗有限责任公司 | 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途 |
WO2020038812A1 (fr) * | 2018-08-20 | 2020-02-27 | Rijksuniversiteit Groningen | Nouveau procédé de préparation d'aménamévir |
TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE227279T1 (de) * | 1995-12-29 | 2002-11-15 | Boehringer Ingelheim Pharma | Phenyl thiazol derivate mit antiherpesvirus eigenschaften |
US6288091B1 (en) * | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
AU3289299A (en) * | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
WO2000029399A1 (fr) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Composes antiherpes |
DE50008597D1 (de) * | 1999-03-08 | 2004-12-16 | Bayer Healthcare Ag | Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel |
JP2003500383A (ja) * | 1999-05-24 | 2003-01-07 | コア・セラピューティクス,インコーポレイテッド | 第Xa因子阻害剤 |
US6545055B1 (en) * | 1999-05-24 | 2003-04-08 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6949543B2 (en) * | 2000-11-10 | 2005-09-27 | Yamanouchi Pharmaceutical Co., Ltd. | Amide derivative |
DE10139060A1 (de) | 2001-08-08 | 2003-02-20 | Merck Patent Gmbh | Phenylderivate |
WO2003095435A1 (fr) | 2002-05-09 | 2003-11-20 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'amides |
TW200505894A (en) * | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
-
2004
- 2004-07-06 TW TW093120267A patent/TW200505894A/zh unknown
- 2004-08-05 JP JP2005513013A patent/JP4549974B2/ja active Active
- 2004-08-05 CA CA2535199A patent/CA2535199C/fr active Active
- 2004-08-05 BR BRPI0413430A patent/BRPI0413430B8/pt active IP Right Grant
- 2004-08-05 PL PL04748296T patent/PL1652843T3/pl unknown
- 2004-08-05 WO PCT/JP2004/011573 patent/WO2005014559A1/fr active Application Filing
- 2004-08-05 DK DK04748296.3T patent/DK1652843T3/da active
- 2004-08-05 US US10/567,565 patent/US7465748B2/en active Active
- 2004-08-05 ES ES04748296.3T patent/ES2462292T3/es active Active
- 2004-08-05 CN CNB2004800222586A patent/CN100445271C/zh active Active
- 2004-08-05 MX MXPA06001526A patent/MXPA06001526A/es active IP Right Grant
- 2004-08-05 SI SI200432152T patent/SI1652843T1/sl unknown
- 2004-08-05 RU RU2006106922/04A patent/RU2336273C2/ru active
- 2004-08-05 KR KR1020067002614A patent/KR101157074B1/ko active IP Right Grant
- 2004-08-05 AU AU2004263448A patent/AU2004263448B2/en active Active
- 2004-08-05 EP EP04748296.3A patent/EP1652843B1/fr active Active
- 2004-08-05 PT PT47482963T patent/PT1652843E/pt unknown
- 2004-08-06 US US10/912,232 patent/US6903125B2/en active Active
-
2006
- 2006-03-07 NO NO20061100A patent/NO335467B1/no unknown
-
2014
- 2014-06-11 CY CY20141100425T patent/CY1115461T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004263448B2 (en) | 2009-02-05 |
CN100445271C (zh) | 2008-12-24 |
KR20060073928A (ko) | 2006-06-29 |
ES2462292T3 (es) | 2014-05-22 |
BRPI0413430B8 (pt) | 2021-05-25 |
KR101157074B1 (ko) | 2012-06-22 |
PT1652843E (pt) | 2014-06-02 |
NO335467B1 (no) | 2014-12-15 |
CY1115461T1 (el) | 2017-01-04 |
US6903125B2 (en) | 2005-06-07 |
NO20061100L (no) | 2006-03-07 |
JP4549974B2 (ja) | 2010-09-22 |
AU2004263448A1 (en) | 2005-02-17 |
EP1652843A1 (fr) | 2006-05-03 |
EP1652843A4 (fr) | 2010-07-28 |
US7465748B2 (en) | 2008-12-16 |
RU2006106922A (ru) | 2006-08-27 |
CN1832930A (zh) | 2006-09-13 |
DK1652843T3 (da) | 2014-05-05 |
TW200505894A (en) | 2005-02-16 |
PL1652843T3 (pl) | 2014-09-30 |
US20050032855A1 (en) | 2005-02-10 |
JPWO2005014559A1 (ja) | 2006-10-05 |
CA2535199A1 (fr) | 2005-02-17 |
EP1652843B1 (fr) | 2014-04-02 |
MXPA06001526A (es) | 2006-05-25 |
TWI341311B (fr) | 2011-05-01 |
RU2336273C2 (ru) | 2008-10-20 |
SI1652843T1 (sl) | 2014-06-30 |
WO2005014559A1 (fr) | 2005-02-17 |
BRPI0413430B1 (pt) | 2019-04-30 |
US20060229295A1 (en) | 2006-10-12 |
BRPI0413430A (pt) | 2006-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2535199C (fr) | Derives d'amide | |
CN108779096B (zh) | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 | |
EP1644320B1 (fr) | Derives d'indane utilises comme agonistes du recepteur muscarinique | |
EP1340750B1 (fr) | Derives amides | |
EP1857108B1 (fr) | Agent preventif ou therapeutique contre une maladie liee au virus de l'herpes | |
CA3008485C (fr) | Composes sulfonamides de dihydroquinoline d'alcynyle | |
JP5011739B2 (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物 | |
CN111978312B (zh) | 5-芳基-1,3,4-噻二唑/1,3,4-噁二唑-2-胺类化合物及制备方法和应用 | |
EP1844775B1 (fr) | Agent thérapeutique pour le traitement de l'herpès génital après le développement de lésions | |
JP3623228B1 (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体 | |
EP1844776B1 (fr) | Agent destine a la prevention/au traitement d'une maladie causee par un virus de l'herpes acyclovir-resistant | |
JP2005089451A (ja) | アミド誘導体又はその塩 | |
JP2004026819A (ja) | 医薬組成物 | |
JP2004026818A (ja) | アミド誘導体又はその塩 | |
JP2006241145A (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |